Skip to main content

Beauty Health Co

For the period ended Dec 31, 2024. Filed Mar 12, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 12, 2025

SKIN$15.71+51.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

THE BEAUTY HEALTH COMPANY
Date:March 12, 2025By:/s/ Marla Beck
Name:Marla Beck
Title:Chief Executive Officer
(Principal Executive Officer)

Power of Attorney

Each person whose individual signature appears below hereby authorizes, constitutes, and appoints Marla Beck and Michael Monahan, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place, and stead, in any and all capacities, to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form 10‑K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, ratifying and confirming that all said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NameTitleDate
/s/ Marla BeckChief Executive Officer and DirectorMarch 12, 2025
Marla Beck(Principal Executive Officer)
/s/ Michael MonahanChief Financial OfficerMarch 12, 2025
Michael Monahan(Principal Financial and Accounting Officer)
/s/ Brenton L. SaundersChairmanMarch 12, 2025
Brenton L. Saunders
/s/ Michael D. CapellasDirectorMarch 12, 2025
Michael D. Capellas
/s/ Stephen J. FanningDirectorMarch 12, 2025
Stephen J. Fanning
/s/ Desiree GruberDirectorMarch 12, 2025
Desiree Gruber
/s/ Michelle KerrickDirectorMarch 12, 2025
Michelle Kerrick
/s/ Brian MillerDirectorMarch 12, 2025
Brian Miller
/s/ Doug SchillingerDirectorMarch 12, 2025
Doug Schillinger
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.